Otsuka Co. (OTCMKTS:OSUKF – Get Free Report) was the target of a large decline in short interest in the month of August. As of August 31st, there was short interest totaling 694,393 shares, a decline of 39.9% from the August 15th total of 1,155,521 shares. Based on an average daily volume of 2 shares, the short-interest ratio is currently 347,196.5 days.
Otsuka Stock Performance
OSUKF stock remained flat at $20.00 during trading on Wednesday. The business has a fifty day moving average of $20.12 and a 200-day moving average of $20.53. Otsuka has a 12-month low of $19.00 and a 12-month high of $21.57.
Otsuka Company Profile
Otsuka Holdings Co, Ltd., traded as OSUKF on the OTC Market, is a global healthcare group headquartered in Tokyo, Japan. The company operates through its principal subsidiary, Otsuka Pharmaceutical Co, Ltd., and is primarily engaged in the research, development and commercialization of pharmaceutical products and nutraceuticals. Its product portfolio spans central nervous system therapies, cardiovascular and metabolic treatments, nephrology, and oncology, alongside a range of consumer wellness goods such as nutritional beverages and dietary supplements.
The origins of the Otsuka group date back to 1921 with the founding of its predecessor firm, and in 2008 the current holding company structure was established to streamline governance and strategic direction.
Featured Articles
- Five stocks we like better than Otsuka
- Holiday Shopping Is Almost Here—And Target May Be Ready to Win Big
- AI Panic Hit Tech Stocks—But NVIDIA’s Growth Engine Is Intact
- 5 Buy-and-Hold Stocks Built to Weather a Volatile Market
- Movado’s Turnaround Gains Momentum
Receive News & Ratings for Otsuka Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Otsuka and related companies with MarketBeat.com's FREE daily email newsletter.
